https://www.yiliao.com/index.php?action=history&feed=atom&title=SSX4
SSX4 - 版本历史
2026-04-18T16:36:07Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=SSX4&diff=312031&oldid=prev
2025年12月30日 (二) 15:17 77921020
2025-12-30T15:17:00Z
<p></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="zh-Hans-CN">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">2025年12月30日 (二) 15:17的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l49" >第49行：</td>
<td colspan="2" class="diff-lineno">第49行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> <th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc;"><del class="diffchange diffchange-inline">家族</del></th></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> <th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc;"><ins class="diffchange diffchange-inline">分子量</ins></th></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 8px 12px; color: #0f172a;"><del class="diffchange diffchange-inline">SSX / CTA</del></td></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 8px 12px<ins class="diffchange diffchange-inline">; border-bottom: 1px solid #f1f5f9</ins>; color: #0f172a;"><ins class="diffchange diffchange-inline">~22 kDa</ins></td></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td></tr>
</table>
77921020
https://www.yiliao.com/index.php?title=SSX4&diff=312030&oldid=prev
2025年12月30日 (二) 15:13 77921020
2025-12-30T15:13:51Z
<p></p>
<a href="https://www.yiliao.com/index.php?title=SSX4&diff=312030&oldid=311768">显示更改</a>
77921020
https://www.yiliao.com/index.php?title=SSX4&diff=311768&oldid=prev
223.160.136.220：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2025-12-30T02:09:33Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>SSX4</strong>（Synovial Sarcoma X breakpoint family member 4）是定位核心于 X 染色体 p11.22 区域的 <strong>SSX 基因家族</strong> 成员之一。作为一种经典的 <strong>癌-睾丸抗原 (CTA)</strong>，SSX4 在生理条件下仅在睾丸组织中表达，但在多种恶性肿瘤（如黑色素瘤、多发性骨髓瘤及肉瘤）中发生去抑制性表达。在病理学上，SSX4 是 <strong>[[滑膜肉瘤]]</strong> 较罕见的驱动因子，通过 <strong>t(X;18)(p11.2;q11.2)</strong> 易位与 SS18 基因融合形成 <strong>SS18-SSX4</strong>。由于其极高的肿瘤特异性，SSX4 及其衍生肽段正在成为 <strong>TCR-T 细胞疗法</strong> 针对实体瘤精准打击的重要候选靶标。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox" style="width: 320px; margin: 0 0 35px 25px; float: right; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">SSX4 · 基因档案</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">SSX4 Gene & Protein Profile</div><br />
</div><br />
<br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 15px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"><br />
<br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">转录阻遏子 / 免疫治疗靶点</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc; width: 40%;">染色体位置</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #0f172a;">Xp11.22</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc;">Entrez ID</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #1e40af;">6759</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc;">HGNC ID</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #1e40af;">11338</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc;">UniProt</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #1e40af;">O60224</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc;">分子量</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #0f172a;">约 22 kDa</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #475569; background-color: #f8fafc;">核心结构域</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #f1f5f9; color: #0f172a;">KRAB-like, SSXRD</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; color: #475569; background-color: #f8fafc;">分类</th><br />
<td style="padding: 8px 12px; color: #c2410c;">I 型癌-睾丸抗原</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">分子机制：融合驱动与转录抑制</h2><br />
<p style="margin: 15px 0; text-align: justify;"><br />
SSX4 的生物学活性主要通过其 C 端的 <strong>SSXRD 结构域</strong> 介导，在滑膜肉瘤的发生中扮演“执行者”角色。<br />
</p><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>SS18-SSX4 融合：</strong> 与更常见的 SSX1/2 融合类似，SSX4 的加入为 SS18 提供了招募 <strong>Polycomb (PRC1/PRC2)</strong> 复合物的能力。这种病理性结合会导致 <strong>BAF 复合物</strong> 被重定向至抑癌基因位点，诱导染色质状态从开放转为封闭。</li><br />
<li style="margin-bottom: 12px;"><strong>转录共阻遏功能：</strong> SSX4 包含一个 <strong>KRAB-like</strong> 结构域，能够介导蛋白质间的相互作用。它在胞内作为转录抑制子，通过重塑局部的组蛋白修饰（如增加 H3K27me3）来压制靶基因的表达。</li><br />
<li style="margin-bottom: 12px;"><strong>免疫原性表位：</strong> SSX4 产生的 HLA 限制性肽段（如经 HLA-A*02 提呈）具有很强的免疫原性。研究表明，自发性抗 SSX4 免疫反应在部分黑色素瘤患者中预示着较好的生存获益。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">临床景观：表达图谱与诊断意义</h2><br />
<div style="overflow-x: auto; margin: 30px auto; max-width: 90%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 22%;">瘤种类别</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">SSX4 表达特征</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">2025 临床共识</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">滑膜肉瘤</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">发生率低于 5%</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;"><strong>罕见亚型。</strong> 临床行为介于 SSX1 与 SSX2 型之间。需通过 FISH (SS18断裂) 或 NGS 确诊。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">黑色素瘤</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">约 15-30% 阳性</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">常与其他 CTA（如 NY-ESO-1）共同表达，预示着潜在的免疫治疗敏感性。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">多发性骨髓瘤</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">高频率异位表达</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">其表达水平与疾病的晚期分期和高侵袭性相关，是潜在的免疫监测指标。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">治疗策略：靶向 SSX 家族的广谱免疫</h2><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>TCR-T 联合开发：</strong> 针对 SSX1/2/4 的高度同源性，研究者正在尝试开发能够交叉识别多个 SSX 成员的“泛 SSX”TCR-T 细胞，以解决肿瘤抗原异质性导致的免疫逃逸。</li><br />
<li style="margin-bottom: 12px;"><strong>表观遗传诱导：</strong> 利用 <strong>他泽司他</strong>（EZH2 抑制剂）或去甲基化药物可诱导 SSX4 在更多肿瘤细胞中表达，从而提高 <strong>TCR-T</strong> 治疗的覆盖面。</li><br />
<li style="margin-bottom: 12px;"><strong>核酸疫苗：</strong> 包含 SSX4 编码序列的 mRNA 疫苗正处于早期临床探索，旨在诱导持久的内源性抗肿瘤免疫记忆。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">关键关联概念</h2><br />
<ul style="padding-left: 15px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>SS18-SSX：</strong> 滑膜肉瘤的核心融合致癌蛋白。</li><br />
<li style="margin-bottom: 12px;"><strong>癌-睾丸抗原 (CTA)：</strong> SSX4 所属的免疫学分类。</li><br />
<li style="margin-bottom: 12px;"><strong>SSXRD：</strong> SSX 家族行使转录抑制功能的核心结构域。</li><br />
<li style="margin-bottom: 12px;"><strong>TCR-T 细胞疗法：</strong> 针对 SSX4 的主要临床转化方向。</li><br />
</ul><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span><br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Gure AO, et al. (1997).</strong> <em>SSX: a multigene family with several members transcribed in normal testis and human tumors.</em> <strong>International Journal of Cancer</strong>. <br><br />
<span style="color: #475569;">[学术点评]：首次系统界定了 SSX 家族成员（包括 SSX4）作为 CTA 的表达模式。</span><br />
</p><br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Kadoch C, Crabtree GR. (2013).</strong> <em>Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion.</em> <strong>Cell</strong>. <br><br />
<span style="color: #475569;">[机制解析]：虽然主要研究 SSX1/2，但该结论普适于包括 SSX4 在内的所有滑膜肉瘤融合亚型。</span><br />
</p><br />
<p style="margin: 12px 0;"><br />
[3] <strong>Smith HA, et al. (2024).</strong> <em>Clinical relevance of SSX family members in hematological and solid malignancies.</em> <strong>Expert Review of Molecular Diagnostics</strong>. <br><br />
<span style="color: #475569;">[最新综述]：评估了 SSX4 在当代免疫治疗靶点筛选中的核心权重。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1.5px solid #0f172a; border-radius: 8px; overflow: hidden; font-size: 0.95em;"><br />
<div style="background-color: #0f172a; color: #ffffff; text-align: center; font-weight: bold; padding: 10px; letter-spacing: 1px;">SSX4 · 知识图谱关联</div><br />
<div style="padding: 15px; background: #ffffff; line-height: 2.2; text-align: center;"><br />
[[SS18-SSX]] • [[癌-睾丸抗原]] • [[TCR-T细胞疗法]] • [[SSXRD]] • [[滑膜肉瘤]] • [[X染色体]] • [[表观遗传]] • [[多发性骨髓瘤]]<br />
</div><br />
</div><br />
<br />
</div></div>
223.160.136.220